Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pd-1 Inhibitors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT06888531
What this trial is testing

Prospective Phase II Clinical Study of Neoadjuvant Chemoradiotherapy Combined With PD-1/PD-L1 Inhibitors in the Treatment of Locally Advanced Resectable Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Malignant Neoplasm Primary
Henan Cancer Hospital 30
Testing effectiveness (Phase 2)Study completedNCT03504488
What this trial is testing

CAB-ROR2-ADC Safety and Efficacy Study in Patients With TNBC or Head & Neck Cancer (Ph1) and NSCLC or Melanoma (Ph2)

Who this might be right for
Non Small Cell Lung CancerTriple Negative Breast CancerMelanoma+1 more
BioAtla, Inc. 132
Testing effectiveness (Phase 2)Active Not RecruitingNCT05340270
What this trial is testing

PD-1 Inhibitor Plus GP as Neoadjuvant Therapy for Locoregionally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal CarcinomaNeoadjuvant TherapyPD-1 Inhibitor
Guangxi Medical University 150
Early research (Phase 1)Active Not RecruitingNCT05615142
What this trial is testing

Safety and Tolerability of Low Dose Radiotherapy Concurrent SBRT and PD-1 Inhibitors in Advanced NSCLC.

Who this might be right for
NSCLCLow Dose RadiotherapyStereotactic Body Radiotherapy+1 more
Sichuan University 9
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06336954
What this trial is testing

Adibelimab, Famitinib and Chemotherapy for Advanced NSCLC After PD-1 Inhibitor Failure

Who this might be right for
Non Small Cell Lung Cancer
Second Affiliated Hospital of Xi'an Jiaotong University 40
Not applicableNot Yet RecruitingNCT07331701
What this trial is testing

Association of BAL Fluid T-Cell Immune Activity With Tumor PD-L1 Expression and Its Prognostic Value: A Prospective Observational Study

Who this might be right for
Lung NeoplasmsTumor Immune Microenvironment
Seoul National University Hospital 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT05130177
What this trial is testing

Zimberelimab (AB122) With TIGIT Inhibitor Domvanalimab (AB154) in PD-1 Relapsed/Refractory Melanoma

Who this might be right for
Melanoma
Diwakar Davar 8
Testing effectiveness (Phase 2)Looking for participantsNCT05563012
What this trial is testing

Short-course Radiotherapy Combined With Neoadjuvant Chemotherapy and PD-1 Inhibitor in the Treatment of Locally Advanced Gastric Adenocarcinoma

Who this might be right for
Disorder in Complete Remission in Response to Treatment
Renmin Hospital of Wuhan University 29
Not applicableUnknownNCT06475196
What this trial is testing

Prospective Cohort Study of Neoadjuvant Therapy With Sintilimab (PD-1 Inhibitor) Combined With Chemotherapy in Resectable ESCC

Who this might be right for
Resectable Esophageal Squamous Cell Carcinoma
Tang-Du Hospital 90
Large-scale testing (Phase 3)Active Not RecruitingNCT06206733
What this trial is testing

ASKB589 in Combination With CAPOX and PD-1 Inhibitor in Patients With Advanced or Metastatic GC/GEJ Adenocarcinoma

Who this might be right for
Gastroesophageal Junction AdenocarcinomaGastric Adenocarcinoma
AskGene Pharma, Inc. 780
Testing effectiveness (Phase 2)Active Not RecruitingNCT04494009
What this trial is testing

PD-1 Inhibitor INCMGA00012 as Consolidation Therapy After Definitive Concurrent Chemoradiotherapy

Who this might be right for
Esophageal Cancer
Asan Medical Center 110
Testing effectiveness (Phase 2)UnknownNCT04252365
What this trial is testing

Sintilimab Versus Pembrolizumab for Advanced-stage Non-Small-Cell Lung Cancer

Who this might be right for
Nsclc
Guangdong Association of Clinical Trials 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT05824481
What this trial is testing

Study of Cadonilimab (AK104) Plus Lenvatinib in Patients With Advanced Endometrial Cancer

Who this might be right for
Endometrial CancerEndometrial Adenocarcinoma
Sun Yat-sen University 32
Early research (Phase 1)UnknownNCT03987867
What this trial is testing

Study of Autologous CIK Cell Immunotherapy Combination With PD-1 Inhibitor and Chemotherapy in the Advanced NSCLC

Who this might be right for
Non-small Cell Lung CancerFirst-line Treatment
Tianjin Medical University Cancer Institute and Hospital 30
Early research (Phase 1)UnknownNCT03491631
What this trial is testing

Phase I Study of SHR9146 + SHR-1210 +/- Apatinib in Patients With Advanced Solid Tumors

Who this might be right for
Tumor, SolidCancer, MetastaticNeoplasm Malignant
Jiangsu HengRui Medicine Co., Ltd. 23
Testing effectiveness (Phase 2)UnknownNCT03048500
What this trial is testing

Nivolumab and Metformin Hydrochloride in Treating Patients With Stage III-IV Non-small Cell Lung Cancer That Cannot Be Removed by Surgery

Who this might be right for
Recurrent Non-Small Cell Lung CarcinomaStage III Non-Small Cell Lung CancerStage IIIA Non-Small Cell Lung Cancer+2 more
Northwestern University 17
Testing effectiveness (Phase 2)Active Not RecruitingNCT04225039
What this trial is testing

Anti-GITR/Anti-PD1/Stereotactic Radiosurgery, in Recurrent Glioblastoma

Who this might be right for
Glioblastoma
University of Pennsylvania 39
Testing effectiveness (Phase 2)Active Not RecruitingNCT06933251
What this trial is testing

PCSK9 Inhibitor and PD-1 Inhibitor Combined With Neoadjuvant Chemoradiotherapy for pMMR/MSS Locally Advanced Rectal Cancer

Who this might be right for
Locally Advanced Rectal Cancer (LARC)
Guangdong Provincial People's Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT07523737
What this trial is testing

Pomalidomide, Anti-PD-1 Antibody Combined With Selinexor (PPS) in Relapsed/Refractory Primary Central Nervous System Diffuse Large B-Cell Lymphoma

Who this might be right for
Primary Central Nervous System Lymphoma (PCNSL)Diffuse Large B Cell Lymphoma (DLBCL)
Beijing Tongren Hospital 43
Testing effectiveness (Phase 2)UnknownNCT05520814
What this trial is testing

PD-1 Inhibitors Plus Chemoradiotherapy for Metastatic Nasopharyngeal Carcinoma: an Open-label Single-arm, Phase II Trial

Who this might be right for
Nasopharyngeal CarcinomaPD-1 InhibitorsChemoradiotherapy
Sichuan Cancer Hospital and Research Institute 50
Next Page